- Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2024€24.4 (+5.17%)Earnings
- EyePoint Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- EyePoint Pharmaceuticals Inc Conference call to discuss topline results TranscriptDec 04, 2023
- EyePoint Pharmaceuticals Inc to Host Virtual Key Opinion Leader TranscriptNov 09, 2023
- Q3 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 01, 2023€5.6 (+0.90%)Earnings
- EyePoint Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - Panel Discussion TranscriptAug 16, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - On-demand TranscriptAug 16, 2023
- Q2 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2023€10.9 (-2.68%)Earnings
- EyePoint Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2023€5.8 (-3.33%)Earnings
- EyePoint Pharmaceuticals Inc at Guggenheim Healthy Altitudes Summit TranscriptMar 15, 2023
- Q4 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2023€2.9 (-7.05%)Earnings
- Q3 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022€5.5 (+0.92%)Earnings
- Q2 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2022€9.05 (+4.02%)Earnings
- EyePoint Pharmaceuticals Inc Investor Day TranscriptJul 18, 2022
- Q1 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€11.2 (-0.88%)Earnings
- EyePoint Pharmaceuticals Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q4 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 03, 2022€8.75 (-3.31%)Earnings
- EyePoint Pharmaceuticals Inc Phase 1 DAVIO Trial Of EYP-1901 Results Conference Call TranscriptNov 13, 2021
- Q3 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€10.6 (+1.92%)Earnings
- EyePoint Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€7.1 (+2.16%)Earnings
- Q1 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€8.7 (-1.14%)Earnings
- Q4 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021€9.6 (-4.00%)Earnings
- EyePoint Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- EyePoint Pharmaceuticals Inc to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD TranscriptDec 04, 2020
- Q3 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€3.8 (+23.38%)Earnings
- Q2 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020€6.06 (-0.98%)Earnings
- Q1 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€8.1 (-6.36%)Earnings
- Q4 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2020€13.1 (-25.14%)Earnings
- Q3 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019€16 (-22.33%)Earnings
- Q2 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€11.03 (+1.75%)Earnings
- Q1 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€14.53 (-2.22%)Earnings
- EyePoint Pharmaceuticals Inc Six-Month Transition Period Ended December 31, 2018 Earnings Call TranscriptMar 14, 2019€22.5 (-1.75%)Earnings
EyePoint Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
We're on. We're going to get started. I'm Jennifer Kim, a biopharma and biotech analyst at Cantor. And I'm looking forward to hosting EyePoint Pharmaceuticals for this fireside chat. We have with us George Elston, CFO of EyePoint .
George, thanks for joining us.
Yeah. Thank you, Jennifer, and I appreciate the opportunity to tell the EyePoint story here at Cantor. We appreciate the invite and looking forward to the discussion.
Okay. Looking forward to it. Maybe to start off, can you introduce and give an overview of the company?
Sure. So EyePoint -- we're based in Watertown, Massachusetts, and we are focused on serious eye disease, leveraging our Durasert technology, which is a well-established technology for sustained delivery of treatments to the eye.
I think we'll
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)